novo nordisk wegovy weight loss

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Novo Nordisk applies for FDA approval in tightening race for weight loss pill

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to approve an oral version of its anti-obesity medication, moving ahead in the race between drugmakers to offer a weight loss pill.

Bloomberg L.P. · 2d

Novo Nordisk Drops on Weight-Loss Study by Rival Lilly

Lilly stock is barely off its highs. Nobles is down really sharply. Yeah. So, guy and good morning to everybody. The issue with Novav

The Motley Fool · 1d

Forget Zepbound: Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly (LLY 0.38%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $

4hon MSN

Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

12hon MSN

FDA stops sale of generic versions of Ozempic and Wegovy: What it means for patients

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

Fierce Pharma2d

Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

Will Indians get blockbuster weight-loss drugs at cost of cheaper insulin?

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

MarketWatch9d

Wegovy, Zepbound makers’ stocks rally as a weight-loss-drug competitor drops out

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We ...

Futurism on MSN5d

Novo Nordisk Is Getting Absolutely Destroyed

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Why Novo Nordisk Stock Popped Today

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP ...

3don MSN

Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

7don MSN

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...

24/7 Wall St.3d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results